Saturday, November 29, 2014 10:20:02 AM
Maybe that person is doing a bunch of due diligence on ONCS' IP to ensure that everything is "in order" before a buyout offer is tendered sometime later in 2015? Who knows.
IF a buyout occurs before any P3 trials have been completed I'd expect it to be for a little less than $1B. Right now I'd say we're worth $200-300M. Still, in any scenario, that's a huge premium from the share price today.
Whatever the case may be, the future is bright for ONCS and cancer patients around the world. At the end of the day, that is what really matters.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM